Recovery from Pure Red Cell Aplasia Caused by Anti-Erythropoietin Antibodies after Kidney Transplantation

American Journal of Transplantation

Volumn 4, Issue 2, 2004, Pages 274-277

  Snanoudj, Renaud ^a   Beaudreuil, Séverine ^a   Arzouk, Nadia ^a   Jacq, Dominique ^b   Casadevall, Nicole ^c   Charpentier, Bernard ^a   Durrbach, Antoine ^a  

^a BICÊTRE HOSPITAL   (France)

^b Nephrology Department   (France)

^c HÔTEL DIEU   (France)

Author keywords

Antithymocyte globulins; Kidney transplantation; Liver transplantation; Pure red cell aplasia; Recombinant erythropoietin

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; ERYTHROPOIETIN ANTIBODY; HORMONE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RECOMBINANT ERYTHROPOIETIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY RESPONSE; ARTICLE; CASE REPORT; HORMONAL THERAPY; HUMAN; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PURE RED CELL ANEMIA;

ANTILYMPHOCYTE SERUM; AUTOANTIBODIES; CHILD; DRUG THERAPY, COMBINATION; ERYTHROPOIESIS; ERYTHROPOIETIN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; RED-CELL APLASIA, PURE; RENAL DIALYSIS;

EID: 1342304220     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1600-6143.2003.00297.x     Document Type: Article

References (12)

1. Casadevall N, Nataf J, Viron B et al. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med 2002; 346: 469-475.
2. Casadevall N. Antibodies against rHuEPO, native and recombinant. Nephrol Dial Transplant 2002; 17: 42-47.
3. Eckardt KU, Casadevall N. Pure red-cell aplasia due to anti-erythropoietin antibodies. Nephrol Dial Transplant 2003; 18: 865-869.
4. Krantz SB. Pure red-cell aplasia. N Engl J Med 1974; 291: 345-350.
5. Casadevall N, Dupuy E, Molho-Sabatier P, Tobelem G, Varet B, Mayeux P. Autoantibodies against erythropoietin in a patient with pure red-cell aplasia. N Engl J Med 1996; 334: 630-633.
6. Sasaki H, Bothner B, Dell A, Fukuda M. Carbohydrate structure of erythropoietin expressed in Chinese hamster ovary cells by a human erythropoietin cDNA. J Biol Chem 1987; 262: 12059-12076.
7. Mayeux P, Billat C, Jacquot R. The erythropoietin receptor of rat erythroid progenitor lens. Characterization and affinity cross-linkage. J Biol Chem 1987; 262: 13985-13990.
8. Gershon SK, Luksenburg H, Cote TR, Braun MM. Pure red-cell aplasia and recombinant erythropoietin. N Engl J Med 2002; 346: 1584-1586.
9. Kruger A, Schroer W, Rohrs F, Vescio G. PRCA in a patient treated with epoetin beta. Nephrol Dial Transplant 2003; 18: 1033-1034.
10. Smith KG, Isbel NM, Catton MG, Leydon JA, Becker GJ, Walker RG. Suppression of the humoral immune response by mycophenolate mofetil. Nephrol Dial Transplant 1998; 13: 160-164.
11. Chng WJ, Tan LK, Liu TC. Cyclospodne treatment for patients with CRF who developed pure red blood cell aplasia following EPO therapy. Am J Kidney Dis 2003; 41: 692-695.
12. Eugui EM, Mirkovich A, Allison AC. Lymphocyte-selective antiproliferative and immunosuppressive effects of mycophenolic acid in mice. Scand J Immunol 1991; 33: 175-183.